» Articles » PMID: 34923709

Vulnerable Exons, Like ACADM Exon 5, Are Highly Dependent on Maintaining a Correct Balance Between Splicing Enhancers and Silencers

Overview
Journal Hum Mutat
Specialty Genetics
Date 2021 Dec 19
PMID 34923709
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

It is now widely accepted that aberrant splicing of constitutive exons is often caused by mutations affecting cis-acting splicing regulatory elements, but there is a misconception that all exons have an equal dependency on splicing regulatory elements and thus a similar susceptibility to aberrant splicing. We investigated exonic mutations in ACADM exon 5 to experimentally examine their effect on splicing and found that 7 out of 11 tested mutations affected exon inclusion, demonstrating that this constitutive exon is particularly vulnerable to exonic splicing mutations. Employing ACADM exon 5 and 6 as models, we demonstrate that the balance between splicing enhancers and silencers, flanking intron length, and flanking splice site strength are important factors that determine exon definition and splicing efficiency of the exon in question. Our study shows that two constitutive exons in ACADM have different inherent vulnerabilities to exonic splicing mutations. This suggests that in silico prediction of potential pathogenic effects on splicing from exonic mutations may be improved by also considering the inherent vulnerability of the exon. Moreover, we show that single nucleotide polymorphism that affect either of two different exonic splicing silencers, located far apart in exon 5, all protect against both immediately flanking and more distant exonic splicing mutations.

Citing Articles

The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer.

Cao M, Yan J, Ding Y, Zhang Y, Sun Y, Jiang G Cell Death Dis. 2025; 16(1):148.

PMID: 40032844 PMC: 11876696. DOI: 10.1038/s41419-025-07458-7.


All exons are not created equal-exon vulnerability determines the effect of exonic mutations on splicing.

Holm L, Doktor T, Flugt K, Petersen U, Petersen R, Andresen B Nucleic Acids Res. 2024; 52(8):4588-4603.

PMID: 38324470 PMC: 11077056. DOI: 10.1093/nar/gkae077.


Regulating gene expression by modulation of pseudoexon splicing patterns to rescue enzyme activity in propionic acidemia.

Spangsberg Petersen U, Dembic M, Martinez-Pizarro A, Richard E, Holm L, Havelund J Mol Ther Nucleic Acids. 2024; 35(1):102101.

PMID: 38204914 PMC: 10776996. DOI: 10.1016/j.omtn.2023.102101.


An intronic RNA element modulates Factor VIII exon-16 splicing.

Tse V, Chacaltana G, Gutierrez M, Forino N, Jimenez A, Tao H Nucleic Acids Res. 2023; 52(1):300-315.

PMID: 37962303 PMC: 10783525. DOI: 10.1093/nar/gkad1034.


Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing.

Varzari A, Deyneko I, Bruun G, Dembic M, Hofmann W, Cebotari V Front Genet. 2022; 13:969895.

PMID: 36338958 PMC: 9632272. DOI: 10.3389/fgene.2022.969895.